Prediction of obstetrical risk using maternal serum markers and clinical risk factors

Prenatal Diagnosis

Volumn 34, Issue 2, 2014, Pages 172-179

  Metcalfe, Amy ^a   Langlois, Sylvie ^a,b   Macfarlane, Julie ^b   Vallance, Hilary ^a   Joseph, K S ^a,c  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN; INHIBIN A; PAPPA1 PROTEIN, HUMAN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AREA UNDER THE CURVE; FEMALE; HELLP SYNDROME; HUMAN; METABOLISM; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; PROCEDURES; REPRODUCIBILITY; REPRODUCTIVE HISTORY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICAL MODEL; STILLBIRTH;

ADULT; ALPHA-FETOPROTEINS; AREA UNDER CURVE; BIOMARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ESTRIOL; FEMALE; HELLP SYNDROME; HUMANS; INHIBINS; LOGISTIC MODELS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; REPRODUCIBILITY OF RESULTS; REPRODUCTIVE HISTORY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SMOKING; STILLBIRTH;

EID: 84895069894     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4281     Document Type: Article

References (25)

1. Brameld KJ, Dickinson JE, O'Leary P, et al. First trimester predictors of adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol 2008;48(6):529-35.
2. Conserva V, Signaroldi M, Mastroianni C, et al. Distinction between fetal growth restriction and small for gestational age newborn weight enhances the prognostic value of low PAPP-A in the first trimester. Prenat Diagn 2010;30:1007-9.
3. Hourrier S, Salomon LJ, Dreux S, Muller F. Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 2010;411(21-22):1547-52.
4. Hui D, Okun N, Murphy K, et al. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. J Obstet Gynaecol Can 2012;34(2):142-53.
5. Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191(4):1452-8.
6. Lain SJ, Algert CS, Tasevski V, et al. Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study. BMC Med Res Methodol 2009;9(48).
7. Morris RK, Cnossen JS, Langejans M, et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth 2008;8:(33).
8. Tul N, Pusenjak S, Osredkar J, et al. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn 2003;23(12):990-6.
9. Audibert F, Boucoiran I, An N, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010;203(4):383 e1-8.
10. Dane B, Dane C, Kiray M, et al. Correlation between first-trimester maternal serum markers, second-trimester uterine artery Doppler indices and pregnancy outcome. Gynecol Obstet Invest 2010;70:126-31.
11. Kang JH, Farina A, Park JH, et al. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 2008;28(8):704-9.
12. Beta J, Akolekar R, Ventura W, et al. Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13weeks. Prenat Diagn 2011;31(1):75-83.
13. Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG 2011;118(9):1042-54.
14. Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Association of first-trimester low PAPP-A levels with preterm birth. Prenat Diagn 2010;30(4):309-13.
15. Spencer K, Cowans NJ, Molina F, et al. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 2008;31(2):147-52.
16. Yuan W, Chen L, Lopez Bernal A. Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2009;145:57-64.
17. Menon R, Torloni MR, Voltolini C, et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci 2011;18(11):1046-70.
18. Conde-Agudelo A, Papageorghiou A, Kennedy S, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG 2013;120(6):681-94.
19. Yu CK, Smith GC, Papageorghiou AT, et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005;193(2):429-36.
20. Caradeux J, Serra R, Nien JK, et al. First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study. Prenat Diagn 2013;33(8):732-6.
21. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108(2):E35.
22. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 2008;149(10):751-60.
23. Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13weeks' assessment. Prenat Diagn 2011;31(1):3-6.
24. Hee L. Likelihood ratios for the prediction of preterm delivery with biomarkers. Acta Obstet Gynecol Scand 2011;90(11):1189-99.
25. Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;30(10):918-49.